Jae Yoon Jeon

机构：The Ohio State University

发表论文 26 篇 · 总被引 482 次 · h-index 11

代表论文

• Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD (2024 · New England Journal of Medicine · 被引 65)
• Pharmacokinetic and Pharmacodynamic Modeling of siRNA Therapeutics – a Minireview (2022 · Pharmaceutical Research · 被引 53)
• Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3 -ITD–Positive AML (2021 · Molecular Cancer Therapeutics · 被引 46)
• Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML (2019 · Investigational New Drugs · 被引 43)
• A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML (2019 · Nature Communications · 被引 41)
• TP-0903 is active in models of drug-resistant acute myeloid leukemia (2020 · JCI Insight · 被引 34)